Limerick, Ireland (October 25, 2017) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), one of the fastest-growing companies in the global biotechnology industry, today announced further expansion of its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus with an additional 300 jobs and investment of $100 million, bringing the total expected employment at the site to 800 people and total investment to $750 million. The project is supported by the government through IDA Ireland.

Read the full article here